Effect of aminoguanidine on myocardial interstitial fibrosis and cardiac function in diabetic rats

Qi-ming DAI,Nai-feng LIU
DOI: https://doi.org/10.3969/j.issn.1006-6187.2012.03.019
2012-01-01
Abstract:Objective To investigate the effect of aminoguanidine on myocardial interstitial fibrosis and cardiac function in diabetic rats,and explore the mechanism of the actions.Methods Thirty male SD rats were randomly divided into 3 groups: normal control,STZ-induced diabetic rats,and diabetic rats treated with aminoguanidine.After 12 weeks,hemodynamics,advanced glycation end products(AGEs) in serum and values of collagen content,the expression of connective tissue growth factor(CTGF) mRNA and protein in the left ventricular tissue were measured.Results Compared with the control,AGEs fluorescence of serum(7.21±2.2 vs 2.63±0.62,P<0.01),collagen content(16±3% vs 12±2%,P<0.01),the expression of CTGF mRNA(0.077±0.0037 vs 0.0102±0.0034,P< 0.01) and protein(0.51±0.01 vs 0.34±0.02,P< 0.01) of myocardium were significantly increased in the diabetic group.The cardiac function was significantly lower in the diabetic group than in the control group.However,the above-mentioned abnormalities were obviously attenuated by administration of aminoguanidine.Conclusions AGEs play an important role in myocardial interstitial fibrosis of diabetic rats.Aminoguanidine can reverse the myocardial interstitial fibrosis and improve the cardiac function by inhibiting the formation of AGEs and down-regulating the over-expression of CTGF.
What problem does this paper attempt to address?